• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤结合抗体B72.3单链Fv变体的多聚化行为

Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3.

作者信息

Desplancq D, King D J, Lawson A D, Mountain A

机构信息

Oncology Department, Celltech Research, Slough, UK.

出版信息

Protein Eng. 1994 Aug;7(8):1027-33. doi: 10.1093/protein/7.8.1027.

DOI:10.1093/protein/7.8.1027
PMID:7809029
Abstract

A systematic study has been performed on the relationship between linker length, relative orientation of variable domains, multimerization behaviour and antigen binding activity for single chain Fvs (scFvs) of the tumour-binding antibody B72.3. Thirteen scFv variants with linkers comprising up to six repeats of the motif Gly-Gly-Gly-Gly-Ser were studied. All these scFvs showed a tendency to form dimers or higher molecular weight species, and this tendency decreased with increasing linker length. The dimers and higher molecular weight forms may arise from head to tail intermolecular association of VH and VL domains. For each linker length, scFvs with the organization VL-linker-VH showed greater binding activity than those with the organization VH-linker-VL. In fact, for the latter organization only the variant with a 30 amino acid linker showed good binding activity, suggesting that (i) for B72.3 the C-terminus of VH or the N-terminus of VL makes a structural contribution to antigen binding, and (ii) shorter linkers interfere with this contribution. Antigen binding studies on scFvs should be interpreted with caution because of their tendency to multimerize. Such multimerization can be minimized by using linkers longer than those in common use.

摘要

针对肿瘤结合抗体B72.3的单链Fv片段(scFv),对连接子长度、可变结构域的相对方向、多聚化行为和抗原结合活性之间的关系进行了系统研究。研究了13种连接子包含多达六个Gly-Gly-Gly-Gly-Ser基序重复序列的scFv变体。所有这些scFv都显示出形成二聚体或更高分子量物种的倾向,并且这种倾向随着连接子长度的增加而降低。二聚体和更高分子量形式可能源于VH和VL结构域的头对头分子间缔合。对于每种连接子长度,具有VL-连接子-VH结构的scFv比具有VH-连接子-VL结构的scFv表现出更高的结合活性。事实上,对于后一种结构,只有具有30个氨基酸连接子的变体显示出良好的结合活性,这表明(i)对于B72.3,VH的C末端或VL的N末端对抗原结合有结构贡献,以及(ii)较短的连接子会干扰这种贡献。由于scFv有形成多聚体的倾向,因此对其进行抗原结合研究时应谨慎解释。通过使用比常用连接子更长的连接子,可以将这种多聚化降至最低。

相似文献

1
Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3.肿瘤结合抗体B72.3单链Fv变体的多聚化行为
Protein Eng. 1994 Aug;7(8):1027-33. doi: 10.1093/protein/7.8.1027.
2
Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv.多价单链抗体片段:单链抗体片段寡聚物的特性及双特异性单链抗体片段的制备
Protein Eng. 1994 Aug;7(8):1017-26. doi: 10.1093/protein/7.8.1017.
3
Comparison of fusion phage libraries displaying VH or single-chain Fv antibody fragments derived from the antibody repertoire of a vaccinated melanoma patient as a source of melanoma-specific targeting molecules.比较展示源自接种疫苗的黑色素瘤患者抗体库的VH或单链Fv抗体片段的融合噬菌体文库,以此作为黑色素瘤特异性靶向分子的来源。
Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9261-6. doi: 10.1073/pnas.94.17.9261.
4
"Diabodies": small bivalent and bispecific antibody fragments.“双抗体”:小型双价双特异性抗体片段。
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6444-8. doi: 10.1073/pnas.90.14.6444.
5
Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains.通过重新排列单链Fv抗体可变区的顺序提高其对c-Met的亲和力。 (注:原文中productivity可能有误,根据语境推测这里可能是指亲和力affinity,上述译文是按照修正后的内容翻译的。若按照原文productivity直接翻译则为:通过重新排列单链Fv抗体可变区的顺序提高其对c-Met的生产力。 )
J Microbiol Biotechnol. 2008 Jun;18(6):1186-90.
6
Functional construction of the anti-mucin core protein (MUC1) antibody MUSE11 variable regions in a bacterial expression system.抗粘蛋白核心蛋白(MUC1)抗体MUSE11可变区在细菌表达系统中的功能构建。
J Biochem. 2000 Apr;127(4):673-9. doi: 10.1093/oxfordjournals.jbchem.a022656.
7
Influences of amino acid sequences in FR1 region on binding activity of the scFv and Fab of an antibody to human gastric cancer cells.FR1区域氨基酸序列对抗体单链抗体片段和Fab片段与人胃癌细胞结合活性的影响
Immunol Lett. 2000 Mar 1;71(3):157-65. doi: 10.1016/s0165-2478(00)00152-8.
8
Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-TAG-72 single-chain Fvs.人源化和基因改组对抗TAG-72单链Fv的免疫原性和抗原结合的影响。
Int J Cancer. 2001 Dec 1;94(5):717-26. doi: 10.1002/ijc.1523.
9
Effect of VH and VL consensus sequence-specific primers on the binding and neutralizing potential of a single-chain FV directed towards HuIFN-gamma.VH和VL共有序列特异性引物对靶向人干扰素-γ的单链FV结合及中和潜力的影响
Mol Immunol. 1995 May;32(7):515-21. doi: 10.1016/0161-5890(95)00010-c.
10
Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.抗MUC1单域抗体片段在毕赤酵母中的过表达。
Mol Immunol. 2006 Feb;43(5):426-35. doi: 10.1016/j.molimm.2005.03.003. Epub 2005 Mar 25.

引用本文的文献

1
Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions.一种双顺反子抗CD19/CD20嵌合抗原受体构建体的开发,包括消除意外的核酸序列缺失。
Mol Ther Oncolytics. 2023 Jul 19;30:132-149. doi: 10.1016/j.omto.2023.07.001. eCollection 2023 Sep 21.
2
Complexities in comparing the impact of costimulatory domains on approved CD19 CAR functionality.比较共刺激结构域对已批准的 CD19 CAR 功能影响的复杂性。
J Transl Med. 2023 Jul 30;21(1):515. doi: 10.1186/s12967-023-04372-4.
3
Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability.
工程化增强型表皮生长因子受体(EGFR)结合剂:西妥昔单抗人源化以改善可开发性
Antibodies (Basel). 2022 Jan 13;11(1):6. doi: 10.3390/antib11010006.
4
Engineering T cells for immunotherapy of primary human hepatocellular carcinoma.工程化 T 细胞用于原发性人肝细胞癌的免疫治疗。
J Genet Genomics. 2020 Jan 20;47(1):1-15. doi: 10.1016/j.jgg.2020.01.002. Epub 2020 Jan 28.
5
Relative Contribution of Framework and CDR Regions in Antibody Variable Domains to Multimerisation of Fv- and scFv-Containing Bispecific Antibodies.抗体可变域中框架区和互补决定区对含Fv和scFv的双特异性抗体多聚化的相对贡献
Antibodies (Basel). 2018 Aug 31;7(3):35. doi: 10.3390/antib7030035.
6
Design and Production of Bispecific Antibodies.双特异性抗体的设计与生产。
Antibodies (Basel). 2019 Aug 2;8(3):43. doi: 10.3390/antib8030043.
7
Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis.用于癌症诊断的靶向离子通道的抗体和抗体片段
Antibodies (Basel). 2019 May 24;8(2):33. doi: 10.3390/antib8020033.
8
Engineering and Design of Chimeric Antigen Receptors.嵌合抗原受体的工程设计
Mol Ther Methods Clin Dev. 2018 Dec 31;12:145-156. doi: 10.1016/j.omtm.2018.12.009. eCollection 2019 Mar 15.
9
Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging.连接子工程改造抗 TAG-72 抗体片段优化了生物物理特性、血清半衰期和高特异性肿瘤成像。
J Biol Chem. 2018 Jun 8;293(23):9030-9040. doi: 10.1074/jbc.RA118.002538. Epub 2018 Apr 18.
10
Production of Single-Chain Fv Antibodies Specific for GA-Pyridine, an Advanced Glycation End-Product (AGE), with Reduced Inter-Domain Motion.特异性结合 GA-吡啶(一种晚期糖基化终产物,AGE)的单链 Fv 抗体的产生,其结构域间运动减少。
Molecules. 2017 Oct 10;22(10):1695. doi: 10.3390/molecules22101695.